Get started
Author

Federico Fama

Coronavirus Disease 19 (COVID-19)
2023 · Andrea Gori, Federico Fama, et al. · Sustainable development goals series · 306
Impact of early antiviral therapy on SARS-CoV-2 clearance time in high-risk COVID-19 subjects: A propensity score matching study
2024 · Marta Colaneri, Federico Fama, et al. · International Journal of Infectious Diseases · 7
PDF
A Case of Myiasis Caused by Cordylobia anthropophaga (Diptera: Calliphoridae) in an Italian Traveler Returning from Senegal
2024 · Alessandro Alvaro, Morena Casartelli, et al. · Acta Parasitologica · 4
Drug resistant tuberculosis in Italy through a global health lens.
2023 · Federico Fama, Camilla Genovese, et al. · PubMed · 2
Andes virus–associated cardiopulmonary syndrome: diagnostic approaches, clinical management, and evidence gaps—a scoping review
2026 · Federico Fama, Francesco Molà, et al. · Clinical Microbiology and Infection · 1
Integrating health into the European Union Migrant and Asylum Pact: a call to action
2024 · Angelo Farina, Doris Zjalic, et al. · The Lancet Regional Health - Europe · 1
Lampedusa Island hotspot is a crucial migrant health checkpoint. Is enough attention being paid?
2023 · D Zjalic, A Farina, et al. · European Journal of Public Health · 1
PDF
Neuropsychological, immunovirological, and socioeconomic profile of transgender women living with HIV: a retrospective cross-sectional study from an Italian reference center
2026 · Giovanni Scaglione, Federico Fama, et al. · Frontiers in Reproductive Health
PDF
Clinical Tuberculosis: Presentation and Diagnostic Approach
2026 · Federico Fama, Jessica Potter, et al. · Cold Spring Harbor Perspectives in Medicine
High frequency of isavuconazole use over voriconazole for chronic pulmonary aspergillosis: a retrospective observational study on tolerability and therapeutic drug monitoring
2026 · Federico Fama, Claudia Conflitti, et al. · Antimicrobial Agents and Chemotherapy
Defining use cases for biomarkers and tests across tuberculosis infection, disease and treatment: An international consensus and prioritisation exercise
2026 · Sacha Wright, Federico Fama, et al. · medRxiv
Barriers and Enablers to the Development and Translation of Tuberculosis Biomarkers and Tests: a Scoping Review Protocol - Extended Data
2026 · Federico Fama · Figshare
A call to action on antimicrobial stewardship in tuberculosis: safeguarding effective tuberculosis treatment for future generations
2026 · Thomas Theo Brehm, Askar Yedilbayev, et al. · The Lancet Regional Health - Europe
Protocol for a scoping review and consensus process to describe and prioritise use cases for biomarkers and tests for tuberculosis
2026 · Sacha Wright, Federico Fama, et al. · Wellcome Open Research
Real-world use of novel β-lactams in immunologically vulnerable patients: insights from an Italian retrospective cohort
2026 · Matilde Bognetti, Federico Fama, et al. · JAC-Antimicrobial Resistance
Diagnostic pathways in returning travellers: integrating Ebola outbreak screening into comprehensive workup
2026 · Alberto Rizzo, Federico Fama, et al. · New Microbes and New Infections
Breaking barriers in extensively drug-resistant TB: pretomanid-centred long regimen achieves cure in a bedaquiline-resistant strain
2026 · M. Schiuma, A. Piubello, et al. · IJTLD OPEN
Biomarkers for Tuberculosis Detection, Progression, and Treatment Optimisation: An Umbrella Review of Systematic Reviews
2026 · Tiffeney Mann, James Greenan-Barrett, et al. · SSRN Electronic Journal
The impact of SARS-CoV-2 VOCs on clinical outcomes: an overview of reviews
2025 · Federico Fama, Rebecca Fattore, et al. · Frontiers in Medicine
PDF
P-1916. The impact of SARS-CoV-2 VOCs on clinical outcomes: an Umbrella Review
2025 · Federico Fama, Rebecca Fattore, et al. · Open Forum Infectious Diseases
PDF
Assessing the prevalence of schistosomiasis and strongyloidiasis in a tuberculosis clinic: the TB-TROPIcare study
2024 · Camilla Genovese, Marta Colaneri, et al. · Frontiers in Tropical Diseases
PDF
Works count: 21
Citation count: 322
H-index: 3
I10-index: 1
Year
Topic
Type